iShares Health Innovation Active ETF (NYSEARCA:BMED) Sees Significant Decline in Short Interest

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the recipient of a significant drop in short interest during the month of August. As of August 14th, there was short interest totaling 2,154 shares, a drop of 73.2% from the July 30th total of 8,033 shares. Approximately 0.6% of the shares of the company are short sold. Based on an average trading volume of 2,286 shares, the days-to-cover ratio is presently 0.9 days.

iShares Health Innovation Active ETF Trading Down 1.8%

Shares of BMED traded down $0.62 during midday trading on Friday, reaching $33.88. The stock had a trading volume of 1,014 shares, compared to its average volume of 3,413. The firm has a market cap of $12.20 million, a PE ratio of 24.91 and a beta of 0.73. The firm has a 50 day simple moving average of $31.46 and a 200-day simple moving average of $29.82. iShares Health Innovation Active ETF has a one year low of $25.79 and a one year high of $34.86.

Institutional Trading of iShares Health Innovation Active ETF

An institutional investor recently bought a new stake in iShares Health Innovation Active ETF stock. Comprehensive Financial Planning Inc. PA bought a new position in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 10,832 shares of the company’s stock, valued at approximately $309,000. Comprehensive Financial Planning Inc. PA owned 3.01% of iShares Health Innovation Active ETF at the end of the most recent quarter.

About iShares Health Innovation Active ETF

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.